Cargando…

Spatial organization of protein aggregates on red blood cells as physical biomarkers of Alzheimer’s disease pathology

Quantifying physical differences of protein aggregates implicated in Alzheimer’s disease (AD), in blood, could provide crucial information on disease stages. Here, red blood cells (RBCs) from 50 patients with neurocognitive complaints and 16 healthy individuals were profiled using an atomic force mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nirmalraj, Peter Niraj, Schneider, Thomas, Felbecker, Ansgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462905/ https://www.ncbi.nlm.nih.gov/pubmed/34559561 http://dx.doi.org/10.1126/sciadv.abj2137

Ejemplares similares

Protein fibril length in cerebrospinal fluid is increased in Alzheimer’s disease
por: Nirmalraj, Peter Niraj, et al.
Publicado: (2023)

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
por: Baird, Alison L., et al.
Publicado: (2015)

Label-Free Digital Holotomography Reveals Ibuprofen-Induced Morphological Changes to Red Blood Cells
por: Bergaglio, Talia, et al.
Publicado: (2023)

Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease
por: Nardini, Matteo, et al.
Publicado: (2022)

The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
por: Inekci, Dilek, et al.
Publicado: (2015)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)

Alzheimer’s Disease-Related Genes Identified by Linking Spatial Patterns of Pathology and Gene Expression
por: Mullins, Roger, et al.
Publicado: (2022)

Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology
por: Grossman, Murray, et al.
Publicado: (2017)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates
por: Moretto, Edoardo, et al.
Publicado: (2022)

Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer’s Disease Patients, Possible Biomarkers for Early Diagnosis
por: Grimaldi, Alfonso, et al.
Publicado: (2019)

Complete aggregation pathway of amyloid β (1-40) and (1-42) resolved on an atomically clean interface
por: Nirmalraj, Peter Niraj, et al.
Publicado: (2020)

Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
por: Dong, Xiaoyu, et al.
Publicado: (2019)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
por: Di Tella, Sonia, et al.
Publicado: (2021)

Blood Hemoglobin, in-vivo Alzheimer Pathologies, and Cognitive Impairment: A Cross-Sectional Study
por: Kim, Jee Wook, et al.
Publicado: (2021)

Nerve Ultrasound as a Decisive Tool in Nonsystemic Vasculitic Neuropathy: A Case Report
por: Leupold, Daniela, et al.
Publicado: (2016)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhang, Xingyu, et al.
Publicado: (2018)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2021)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer’s mice
por: Castro-Alvarez, John F., et al.
Publicado: (2014)

Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer’s Disease Pathology and Shows Differential Expression in Transgenic Mice
por: Bonham, Luke W., et al.
Publicado: (2018)

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
por: Yu, Lei, et al.
Publicado: (2021)

The buckling instability of aggregating red blood cells
por: Flormann, Daniel, et al.
Publicado: (2017)

A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer’s Disease
por: Kakraba, Samuel, et al.
Publicado: (2019)

Neuroprotective effects of resveratrol in Alzheimer disease pathology
por: Rege, Shraddha D., et al.
Publicado: (2014)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer’s Type Dementia
por: Pretorius, Lesha, et al.
Publicado: (2018)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
por: de Vidania, Silvia, et al.
Publicado: (2020)

An Imaging and Blood Biomarkers Open Dataset on Alzheimer's Disease vs. Late Onset Bipolar Disorder
por: Besga, Ariadna, et al.
Publicado: (2020)

An atlas on biomarkers for Alzheimer's disease
por: Martínez-Rivera, Marta
Publicado: (2013)

Insights Into the Mechanism of Tyrosine Nitration in Preventing β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhao, Jie, et al.
Publicado: (2021)

Amyloid-beta aggregation implicates multiple pathways in Alzheimer’s disease: Understanding the mechanisms
por: Iliyasu, Musa O., et al.
Publicado: (2023)

Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology
por: Tsujikawa, Koyo, et al.
Publicado: (2022)

Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways
por: Perényi, Helga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_24m1mrfs1ao9mgs4nlvb50r6td